Hand Sanitizers

• Video--Safely Using Hand Sanitizer
• Podcast--FDA Insight: Hand Hygiene During COVID-19
• Safely Using Hand Sanitizer
• FDA Warns Consumers About Hand Sanitizer Packaged in Food and Drink Containers
• Is Your Hand Sanitizer on FDA’s List of Products You Should Not Use?
• FDA Updates on Hand Sanitizers with Methanol Contamination
• FDA advises consumers not to use hand sanitizer products manufactured by Eskbiochem
• FDA Takes Action to Protect Public Health; Increase Supply of Alcohol-Based Hand Sanitizer
• FDA Continues to Ensure Availability of Alcohol-Based Hand Sanitizer During the COVID-19 Pandemic, Addresses Safety Concerns
• Q&A for Consumers: Hand Sanitizers and COVID-19
• FDA provides guidance on production of alcohol-based hand sanitizer to help boost supply, protect public health

Testing

• Find a community-based testing site for COVID-19 near you
• FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19
• FDA Issues New Authorization for the BinaxNOW COVID-19 Ag Card Home Test
• FDA Authorizes First Direct-to-Consumer COVID-19 Test System
• FDA Authorizes First COVID-19 and Flu Combination Test for use with home-collected samples
• FDA Authorizes First COVID-19 Test for Self-Testing at Home
• Recommendations on Providing Clear Instructions to Patients Who Self-Collect an Anterior Nares (Nasal) Sample in a Health Care Setting for SARS-CoV-2 Testing - Letter to Health Care Providers
• FDA Authorizes First Diagnostic Test Where Results Can Be Read Directly From Testing Card
• FDA’s Ongoing Work to Support and Advance COVID-19 Diagnostic Test Accuracy and Availability
• FDA Issues First Emergency Authorization for Sample Pooling in Diagnostic Testing
• Podcast--FDA Insight: All About COVID-19 Testing
• Video--An Introduction to COVID-19 Tests
• FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection
• FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection
• Coronavirus Testing Basics
• FDA Authorizes First Standalone At-Home Sample Collection Kit That Can Be Used With Certain Authorized Tests
• FDA Informs Public About Possible Accuracy Concerns with Abbott ID NOW Point-of-Care Test
• FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients
• FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens
• FDA Authorizes First Test for Patient At-Home Sample Collection
• FDA, Gates Foundation, UnitedHealth Group, Quantigen, and U.S. Cotton Collaborate to Address Testing Supply Needs

Serological Tests (antibodies)

• FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
• Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers
• FDA Issues Warning Letters to Companies Inappropriately Marketing Antibody Tests, Potentially Placing Public Health at Risk
• FDA Provides Promised Transparency for Antibody Tests
• Serological Test Validation and Education Efforts
• Serological tests to detect the body’s immune response to the infection caused by the virus
• FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19

Treatment Options

• FDA Approves First Treatment for COVID-19

Vaccine Information

• Pfizer-BioNTech COVID-19 Vaccine Frequently Asked Questions
• FDA Announces Advisory Committee Meeting (December 17, 2020) to Discuss Second COVID-19 Vaccine Candidate: request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna Inc.
• FDA Announces Advisory Committee Meeting (December 10, 2020) to Discuss COVID-19 Vaccine Candidate: Request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH
• Vaccine Development – 101
• Emergency Use Authorization for Vaccines Explained
• The Path for a COVID-19 Vaccine from Research to Emergency Use Authorization
• The FDA’s Vaccines and Related Biological Products Advisory Committee and its Role in Advising the Agency on COVID-19 Vaccines
• Podcast--FDA Insight: Advisory Committee on COVID-19 Vaccines
• Video--Tell Me More About Vaccines
• FDA In Brief: FDA Issues Guidance on Emergency Use Authorization for COVID-19 Vaccines
• FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccines
  • October 22, 2020 Meeting Announcement: Vaccines and Related Biological Products Advisory Committee
• FDA COVID-19 Vaccine Information
• The FDA’s Scientific and Regulatory Oversight of Vaccines is Vital to Public Health
• Podcast--FDA Insight: Vaccines for COVID-19, Part 1
• Podcast--FDA Insight: Vaccines for COVID-19, Part 2

Emergency Use Authorization (EUA)

• FDA Authorizes Drug Combination for Treatment of COVID-19
• FDA Authorizes Monoclonal Antibody for Treatment of COVID-19
• What is an Emergency Use Authorization (EUA)?
• FDA Reissues Emergency Use Authorization for Certain Non-NIOSH-Approved Filtering Face-Piece Respirators Manufactured in China
• FDA Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19
• Fact Sheet for Patients And Parents/Caregivers Emergency Use Authorization (EUA) Of Veklury® (remdesivir) For Coronavirus Disease 2019 (COVID-19)
• FDA Includes Ventilator Developed by NASA in Ventilator Emergency Use Authorization
• FDA Authorizes Blood Purification Device to Treat COVID-19

FDA's Coronavirus Treatment Acceleration Program

• Coronavirus Treatment Acceleration Program (CTAP)
• An Update and Behind the Scenes: FDA’s Coronavirus Treatment Acceleration Program
• Ensuring the Safety of Patients in Clinical Trials Studying Investigational New Drugs to Prevent or Treat COVID-19
• Podcast--FDA Insight: Clinical Trials and Treatments for COVID-19
• FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems
• Medical Devices and the COVID-19 (Coronavirus) Pandemic
• Partnering with the European Union and Global Regulators on COVID-19
• FDA Takes Additional Action to Harness Real-World Data to Inform COVID-19 Response Efforts
• Bringing a Cancer Doctor’s Perspective to FDA’s Response to the COVID-19 Pandemic
• Understanding the Regulatory Terminology of Potential Preventions and Treatments for COVID-19
• FDA Takes New Actions to Accelerate Development of Novel Prevention, Treatment Options for COVID-19
• FDA Reiterates Importance of Close Patient Supervision for ‘Off-Label’ Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems
• The Path Forward: Coronavirus Treatment Acceleration Program
• FDA Continues to Accelerate Development of Novel Therapies for COVID-19
• FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19

Information on Donating Blood and Plasma

• Video--Donate Blood and Plasma to Make a Difference
• FDA Encourages Recovered Patients to Donate Plasma for Development of Blood-Related Therapies
• Donate COVID-19 Plasma
• Blood Donations
• FDA Provides Updated Guidance to Address the Urgent Need for Blood During the Pandemic

Fake Products

• Protect Your Family From Fraudulent Flu Products
• Video--Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments
• Danger: Don’t Drink Miracle Mineral Solution or Similar Products
• FDA Protects Patients and Consumers from Fraud During COVID-19
• Federal judge enters temporary injunction against Xephyr LLC doing business as N-Ergetics, preventing sale of Colloidal Silver Products for COVID-19
• FDA Continues to Combat Fraudulent COVID-19 Medical Products
• Fraudulent Coronavirus Disease 2019 (COVID-19) Products
• Federal judge enters temporary injunction against Genesis II Church of Health and Healing, preventing sale of Chlorine Dioxide Products Equivalent to Industrial Bleach to Treat COVID-19
• FDA Warns Seller Marketing Dangerous Chlorine Dioxide Products that Claim to Treat or Prevent COVID-19
• FDA Alerts Consumers About Unauthorized Fraudulent COVID-19 Test Kits
• Report Fraudulent Products

Medical Product (drug, biologic, device) Shortages

Do you have questions or concerns regarding possible medical product (drug, biologic, device) shortages?

To report any potential or actual drug shortage:
Email: drugshortages@fda.hhs.gov
Phone: (240) 402-7770
Click here to search the Drug Shortages Database

To report any potential or actual biological product shortage:
Email: CBERshortage@fda.hhs.gov
Phone: (240) 402-8380
Click here to see CBER-Regulated Products: Current Shortages

To report any potential or actual shortage of a medical device or radiation-emitting product:
Email: DeviceShortages@fda.hhs.gov
Phone: 1-800-638-2041 or (301) 796-7100

Clinical Trials

Are you a patient currently enrolled in a clinical trial? You may have questions about the status of your trial during the COVID-19 pandemic. FDA encourages you to contact your clinical trial investigator and healthcare team about the trial and your care.

Check out FDA’s Q&A for more information.

FDA’s Expanded Access Program

Expanded access is a potential pathway for your licensed physician/doctor to take if trying an investigational product (drug, biologic, or medical device) for treatment is right for you.

• Institutional Review Board (IRB) Review of Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products During the COVID-19 Public Health Emergency Guidance for IRBs and Clinical Investigators
• Learn About Expanded Access and Other Treatment Options
• Expanded Access: Information for Patients
• Expanded Access for Medical Devices
• Patients Matter Video: Learn about Expanded Access

Food Safety

• Food Safety and the Coronavirus Disease 2019 (COVID-19)
• FDA's Food and Cosmetics Information Center Answers Your Questions
• Podcast--FDA Insight: Food Safety and COVID-19
• Pandemic Challenges Highlight the Importance of the New Era of Smarter Food Safety
• Best Practices for Re-Opening Retail Food Establishments During the COVID-19 Pandemic
• Video--12 Tips for Grocery Shopping During the Pandemic
• Video--FDA: Food Access and COVID-19
• Video--What You Need to Know: Food and COVID-19 PSA with Frank Yiannas
• Shopping for Food During the COVID-19 Pandemic
• Food Safety and Availability During the Coronavirus Pandemic
• FDA Offers Assurance About Food Safety and Supply for People and Animals During COVID-19

Additional COVID-19 Information for Patients

Centers for Disease Control and Prevention (CDC) has online COVID-19 resources with advice on how to protect yourself and what to do if you become ill.

• CDC COVID-19 Guidance
• COVID-19 in Racial and Ethnic Minority Groups
• FAQ videos on COVID-19
• How to Protect Yourself
• Masks: Wear a Mask. Protect Others.

Reagan-Udall Foundation for the FDA: COVID-19 Hub

Smithsonian Science Education Center and the World Health Organization (WHO) launched a curriculum for youth ages 8-17 (available in over 15 languages) to better understand the current pandemic.

• COVID-19! How Can I Protect Myself and Others? (English)
• COVID-19! How Can I Protect Myself and Others? (additional languages)